Yesterday I saw a new Neuro that I was aware was aggressive in research study involvement (not my thing but there are few MS neuros in town and I needed a doc that would return my calls 😕)
Of course he is trying to have me enroll in a study. This is with a new class of drug called BTK1. It works on both B cells and microglia.
I’m going to do some homework but wondered if anyone was in a similar study or had any info? TIA ☺️
Written by
erash
To view profiles and participate in discussions please or .
I remember seeing something a couple of years ago about this, but after looking it up, it looks promising. The side effects listed so far don't seem serious. Are you thinking about getting involved in this study?
I agree, btk1’s sound very interesting. Unfortunately the study I’m eligible for would randomize me to either Ocrevus or fenebrutinib for more than 2 years, without me knowing which, would require contrast MRI every 3-6 mos. ☹️
How would I know? You get the Btk1 or a placebo pill daily plus Ocrevus or a placebo infusion every 6 mos. So you get either a placebo pill or a placebo infusion...I don't think I would know if effects/side effects are from one or the other???
I wouldn’t be going for it either. I hope so. I’m curious about making a combo treatment with it with other meds, so it seems like they could take someone who just stopped O and given them x and or placebo to flesh that combo theory out at the same time, and save us many years waiting.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.